The petition urges the agency to do away with an “unnecessary” and “burdensome” regulatory framework that significantly limits access to this medication.

Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, attorneys general from four pro-abortion states have fired back, filing (PDF) a petition asking the U.S. regulator to lift restrictions on the treatment.